California-based DNAnexus has raised $58m in a round led by Foresite Capital and featuring participation from Richard Daly (formerly Google Ventures), and Microsoft. DNAnexus has developed a cloud-based platform enabling scientists from all fields to access and manage DNA sequencing information, and recently integrated Google Brain’s DeepVariant into the platform. DNAnexus CEO GV said the funds would be used to expand its presence in the clinical trials sector and help launch the company's translational medicine solutions.
California-based DNAnexus has raised $58m in a round led by Foresite Capital and featuring participation from GV (formerly Google Ventures), and Microsoft. DNAnexus has developed a cloud-based platform enabling scientists from all fields to access and manage DNA sequencing information, and recently integrated Google Brain’s DeepVariant into the platform. DNAnexus CEO Richard Daly said the funds would be used to expand its presence in the clinical trials sector and help launch the company's translational medicine solutions.